Reducing the frequency of eye screening in patients with diabetes from annually to every other year would delay detection of sight-threatening diabetic retinopathy (STDR) and proliferative diabetic ...

SECAUCUS, N.J., April 4, 2022 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced a collaboration with IRIS (Intelligent ...

AI-based retinal imaging and diagnostics startup AEYE Health announced today it received clearance from the FDA to market its diagnostic screening system for diabetic retinopathy. There are 35 million ...

Please provide your email address to receive an email when new articles are posted on . The use of artificial intelligence in screening for diabetic retinopathy led to accurate referrals in Rwanda ...

One-third of diabetic adults in the U.S. do not receive annual eye exams. Additionally, lack of pupillary dilation before exams is associated with ungradable, or insufficient exams. In September 2022, ...

Clinic Cuff Measurements in Accuracy and Stability NEW YORK, /PRNewswire/ -- AEYE Health, the leader in ophthalmic AI and retinal diagnostics and the developer of AEYE-DS, the fastest growing solution ...

Despite its underutilization, AI-powered diabetic retinopathy screening was associated with greater OCT referral rates than traditional screening methods. Artificial intelligence (AI)-based diabetic ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The retrospective cohort study evaluated patients who ...

Implementation this month of a longer screening interval for diabetic eye disease for patients deemed 'low risk' could result in delays in critical hospital referral, researchers from a London-led ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. This piece also marks part ...